The second General Assembly meeting of the AD-RIDDLE (“Real-World Implementation, Deployment, and Validation of Early Detection Tools and Lifestyle Enhancement”) project took place in London on 10–11 June 2025. Hosted by Imperial College London, this two-day event brought together representatives from 24 partner organisations across academia, healthcare, industry and non-profit sectors to discuss different work packages and facilitate partnerships. AD-RIDDLE centres around a toolbox platform concept, providing a series of validated tools at each key step to enable healthcare systems and practitioners to improve the management of Alzheimer’s disease (AD) and dementia across diverse patient populations. The AD-RIDDLE platform aims to transform how AD is detected and diagnosed, prevented and treated across healthcare settings.
The first day concluded with an inspiring talk by Trevor Salomon, Chairperson of the European Dementia Carers Working Group (EDCWG), who shared his personal experiences as a caregiver. Within the consortium, Alzheimer Europe leads two work packages concerning facilitation of the real-world implementation of AD-RIDDLE (e.g., ethical, policy, health economic considerations) as well as communication and public involvement. Angela Bradshaw (Director for Research), Dianne Gove (Director for Public Involvement and Ethics), Ana Diaz (Public Involvement Lead), Cindy Birck (Project Officer) and Lukas Duffner (Project Officer) joined the meeting on behalf of Alzheimer Europe. The AD-RIDDLE project has received funding from the Innovative Health Initiative 2 Joint Undertaking (JU), under grant agreement No 101132933 (2024-2029). The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, EuropaBio, MedTech Europe and Vaccines Europe, with Davos Alzheimer’s Collaborative, Combinostics OY., Cambridge Cognition Ltd., C2N Diagnostics LLC, and neotiv GmbH.
https://www.ad-riddle.org/resources/ad-riddle-convenes-its-second-general-assembly-in-london